Publication
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
Norbert Stefan, Markus Ramsauer, Paul Jordan, Bettina Nowotny, Konstantinos Kantartzis, Jürgen Machann, Jong-Hee Hwang, Peter Nowotny, Sabine Kahl, Jürgen Harreiter, Silke Hornemann, Arun J Sanyal, Paul M Stewart, Andreas F Pfeiffer, Alexandra Kautzky-Willer, Michael Roden, Hans-Ulrich Häring, Sabine Fürst-Recktenwald
The Lancet Diabetes & Endocrinology, May 2014, Elsevier
DOI: 10.1016/s2213-8587(13)70170-0